Related Experiment Video
Updated: May 17, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis
Gemma Mayol1, José I Martín-Subero, José Ríos
1Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Fundación Sant Joan de Déu, Barcelona, Spain.
Abstract:
Neuroblastoma (NB) pathogenesis has been reported to be closely associated with numerous genetic alterations. However, underlying DNA methylation patterns have not been extensively studied in this developmental malignancy. Here, we generated microarray-based DNA methylation profiles of primary neuroblastic tumors. Stringent supervised differential methylation analyses allowed us to identify epigenetic changes characteristic for NB tumors as well as for clinical and biological subtypes of NB. We observed that gene-specific loss of DNA methylation is more prevalent than promoter hypermethylation. Remarkably, such hypomethylation affected cancer-related biological functions and genes relevant to NB pathogenesis such as CCND1, SPRR3, BTC, EGF and FGF6. In particular, differential methylation in CCND1 affected mostly an evolutionary conserved functionally relevant 3' untranslated region, suggesting that hypomethylation outside promoter regions may play a role in NB pathogenesis. Hypermethylation targeted genes involved in cell development and proliferation such as RASSF1A, POU2F2 or HOXD3, among others. The results derived from this study provide new candidate epigenetic biomarkers associated with NB as well as insights into the molecular pathogenesis of this tumor, which involves a marked gene-specific hypomethylation.
Insights
Neuroblastoma (NB) pathogenesis involves significant DNA methylation changes. Gene-specific hypomethylation, particularly in CCND1, is more prevalent than hypermethylation, offering new epigenetic biomarkers for this developmental malignancy.
Area of Science:
- Oncology
- Epigenetics
- Developmental Biology
Background:
- Neuroblastoma (NB) pathogenesis is linked to genetic alterations, but DNA methylation patterns remain understudied.
- Understanding epigenetic modifications is crucial for deciphering NB development and identifying therapeutic targets.
Purpose of the Study:
- To investigate genome-wide DNA methylation profiles in primary neuroblastoma tumors.
- To identify specific epigenetic changes associated with NB and its subtypes.
- To explore the role of DNA methylation in NB pathogenesis.
Main Methods:
- Generation of microarray-based DNA methylation profiles from primary neuroblastic tumors.
- Application of stringent supervised differential methylation analyses.
- Identification and characterization of differentially methylated genes and regions.
Main Results:
- Gene-specific DNA hypomethylation is more prevalent than promoter hypermethylation in NB.
- Hypomethylation affects cancer-related genes (e.g., CCND1, SPRR3, BTC, EGF, FGF6) and NB pathogenesis.
- Hypermethylation targets genes involved in cell development and proliferation (e.g., RASSF1A, POU2F2, HOXD3).
- Differential methylation in CCND1's 3' untranslated region suggests roles for non-promoter methylation.
Conclusions:
- DNA methylation patterns, particularly gene-specific hypomethylation, are integral to neuroblastoma pathogenesis.
- Identified epigenetic alterations provide candidate biomarkers for NB diagnosis and prognosis.
- Findings offer novel insights into the molecular mechanisms driving this developmental malignancy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

